Aquablation for Benign Prostatic Hyperplasia: A Prospective Study with Comparative Analysis of Transurethral Resection of the Prostate and Holmium Laser Enucleation

Abstract

Introduction:

Benign prostatic hyperplasia is a leading cause of lower urinary tract symptoms in aging men. When medical therapy fails, surgery is indicated. This study evaluates the safety and efficacy of Aquablation compared with transurethral resection of the prostate (TURP) and Holmium laser enucleation of the prostate (HoLEP) in patients with bladder outlet obstruction.

Methods and Materials:

A prospective analysis of 318 Aquablation patients (2023–2025) was conducted and compared with 83 TURP and 83 HoLEP patients from a retrospective database. Functional outcomes were assessed using International Prostate Symptom Score (IPSS), ICIQ-UI, EF-IIEF, and MSHQ-EJD SF. Complications were graded using the Clavien-Dindo classification. Follow-ups were performed at 3, 6, and 12 months.

Results:

Aquablation patients had larger prostates than TURP (94 versus 54.7 cc; P < .0001) but smaller than HoLEP (105 cc; P = .002) patients. More Aquablation patients had indwelling catheters and were on anticoagulants (P < .0001). IPSS improvement was the greatest in Aquablation (18.9 points) versus TURP (13.8) and HoLEP (14.7; P = .000). Erectile function was preserved in Aquablation (P = .859), with significantly better ejaculatory function (82.8% preserved) than TURP (36%) and HoLEP (18%). Furthermore, Clavien-Dindo grade 1–2 complications were higher in Aquablation, but serious events (CD 3–4) were comparable. Complication rates declined significantly after the first 30 Aquablation cases.

Conclusion:

Aquablation is an effective surgical option for medium to large prostates, offering superior symptom relief and preservation of sexual function. Although its learning curve is shorter than HoLEP’s, proper training is essential to minimize early complications.

Keywords

Aquablation benign prostatic hyperplasia bladder outlet obstruction TURP

Get full access to this article

View all access options for this article.

References

Berry

, Coffey

, Walsh

, et al. The development of human benign prostatic hyperplasia with age. J Urol, 1984; 132(3):474–479; doi: 10.1016/s0022-5347(17)49698-4

Parsons

, Dahm

, Köhler

, et al. Surgical management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA Guideline Amendment 2020. J Urol, 2020; 204(4):799–804; doi: 10.1097/JU.0000000000001298

McVary

. BPH: Epidemiology and comorbidities. Am J Manag Care, 2006; 12(5 Suppl):S122–S128.

Gravas

, Cornu

, Gacci

, Drake

, et al. EAU Guidelines on the Management of Non-Neurogenic Male Lower Urinary Tract Symptoms (LUTS), including Benign Prostatic Obstruction (BPO). European Association of Urology; 2024. Available at: https://d56bochluxqnz.cloudfront.net/documents/full-guideline/EAU-Guidelines-on-Non-Neurogenic-Male-LUTS-2024.pdf

Foster

, Barry

, Dahm

, et al. Surgical management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA Guideline. J Urol, 2018; 200(3):612–619; doi: 10.1016/j.juro.2018.05.048

Bach

, Gilling

, El Hajj

, et al. First multi-center all-comers study for the aquablation procedure. J Clin Med, 2020; 9(2):603; doi: 10.3390/jcm9020603

Rassweiler

, Teber

, Kuntz

, et al. Complications of transurethral resection of the prostate (TURP)–incidence, management, and prevention. Eur Urol, 2006; 50(5):969–979; discussion 980; doi: 10.1016/j.eururo.2005.12.042

Stein

, Cox

, Hauser

, et al. Evolution of AquablationVR-From innovation to establishment. Turk J Urol, 2021; 47(5):351–357; doi: 10.5152/tud.2021.21126, 35118974

Nguyen

, Barber

, Bidair

, et al. WATER versus WATER II 2-year update: Comparing aquablation therapy for benign prostatic hyperplasia in 30-80-cm³ and 80-150-cm³ prostates. Eur Urol Open Sci, 2021; 25:21–28; doi: 10.1016/j.euros.2021.01.004

10.

Desai

, Singh

, Abhishek

, et al. Aquablation therapy for symptomatic benign prostatic hyperplasia: A single-centre experience in 47 patients. BJU Int, 2018; 121(6):945–951; doi: 10.1111/bju.14126

11.

Magistro

, Chapple

, Elhilali

, et al. Emerging minimally invasive treatment options for male lower urinary tract symptoms. Eur Urol, 2017; 72(6):986–997; doi: 10.1016/j.eururo.2017.07.005

12.

Nguyen

, Misraï

, Bach

, et al. Operative time comparison of aquablation, greenlight PVP, ThuLEP, GreenLEP, and HoLEP. World J Urol, 2020; 38(12):3227–3233; doi: 10.1007/s00345-020-03137-8

13.

Magistro

, Schott

, Keller

, et al. Enucleation vs. resection: A matched-pair analysis of TURP, HoLEP and bipolar TUEP in medium-sized prostates. Urology, 2021; 154:221–226; doi: 10.1016/j.urology.2021.04.004

14.

Gilling

, Barber

, Bidair

, et al. WATER: A double-blind, randomized, controlled trial of Aquablation® vs transurethral resection of the prostate in benign prostatic hyperplasia. J Urol, 2018; 199(5):1252–1261; doi: 10.1016/j.juro.2017.12.065

15.

Gilling

, Barber

, Bidair

, et al. Five-year outcomes for Aquablation therapy compared to TURP: Results from a double-blind, randomized trial in men with LUTS due to BPH. Can J Urol, 2022; 29(1):10960–10968.

16.

Bachmann

, Tubaro

, Barber

, et al. 180-W XPS GreenLight laser vaporisation versus transurethral resection of the prostate for the treatment of benign prostatic obstruction: 6-month safety and efficacy results of a European Multicentre Randomised Trial–the GOLIATH study. Eur Urol, 2014; 65(5):931–942; doi: 10.1016/j.eururo.2013.10.040

17.

Briganti

, Naspro

, Gallina

, et al. Impact on sexual function of holmium laser enucleation versus transurethral resection of the prostate: Results of a prospective, 2-center, randomized trial. J Urol, 2006; 175(5):1817–1821; doi: 10.1016/S0022-5347(05)00983-3

18.

Nguyen

, Mantri

, Zorn

, et al. Which anatomic structures should be preserved during aquablation contour planning to optimize ejaculatory function? A case-control study using ultrasound video recordings to identify surgical predictors of postoperative anejaculation. Urology, 2021; 153:250–255; doi: 10.1016/j.urology.2021.01.023

19.

Gratzke

, Schlenker

, Seitz

, et al. Complications and early postoperative outcome after open prostatectomy in patients with benign prostatic enlargement: Results of a prospective multicenter study. J Urol, 2007; 177(4):1419–1422; doi: 10.1016/j.juro.2006.11.062